Clinical Trial Results TV
Trial / Study: 676 submissions (showing 526 to 540)

| Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44 | Page 45 | Page 46 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Junbo Ge and Dr. C. Michael Gibson discuss the results of the NO REFLOW Trial
Dr. C. Michael Gibson, MD, Dr. Ge Junbo

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Sanjay Kaul and Dr. C. Michael Gibson discuss the findings of the PLATO trial
Dr. Sanjay Kaul, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Flavio Ribichini and Dr. C. Michael Gibson discuss the results of the CEREA-DES Trial
Dr. C. Michael Gibson, MD, Dr. Flavio Ribichini

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Josef Veselka and Dr. C. Michael Gibson discuss the STATINS PRE-PCI Trial
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Robert Byrne and Dr. C. Michael Gibson discuss the ISAR-DESIRE 2 Trial
Dr. Robert Byrne, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Stephan Windecker and Dr. C. Michael Gibson discuss the results of the SIRTAX-LATE Trial from TCT 2009
Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. William Fearon and Dr. C. Michael Gibson discuss the 2-year results of the FAME Study from TCT 2009
Dr. C. Michael Gibson, , Dr. William Fearon

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Harrington and Dr. Gibson discuss the role of CRP in cardiovascular disease
Dr. Robert Harrington, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CTA
Dr. Robert Harrington, MD, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Matthew Price on a DES Marinade
Dr. Matthew Price

1 Star 2 Star 3 Star 4 Star 5 Star
SCAI Press Conference for the Zilver and AMADEUS trials, and to announce the new expert consensus paper on length of sta
Dr. Baghat Reddy, Dr. Tomasz Siminiak, Dr. James Hermiller, Dr. Gregory Dehmer, Dr. Carl Tommaso, Dr. Charles Chambers

1 Star 2 Star 3 Star 4 Star 5 Star
The Clopidogrel Medco Outcomes Study on the possible effects of clopidogrel and heart burn medications known as PPIs
Dr. Steven Bailey, Dr. Eric Stanek

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Rajesh Dave presents the preliminary results of the CRYSTAL AMI Study
Dr. Raj Dave

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. George Dangas and Dr. C. Michael Gibson discuss the HORIZONS-AMI Trial
Dr. C. Michael Gibson, Dr. George Dangas